Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986148 · ClinicalTrials.gov registry record · NA

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

A NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
4
Study locations

NCT06986148 is a NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP) that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 2,000 participants, below the 108,899-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (98% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986148, a NA study of Community-acquired Pneumonia and Community Acquired Pneumonia (CAP), is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.

Interventions

  • OTHER Immediate Antibiotic Prescribing Group Instructions
  • OTHER Safety Net Antibiotic Prescribing (SNAP) Group Instructions

Study Locations (4)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Utah

  • Primary Children's Hospital - Salt Lake City

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-09-09
Est. Completion 2029-07-16
Phase NA

What the Registry Record Tells You About NCT06986148

The ClinicalTrials.gov registry entry for NCT06986148 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108,899-participant average among 9 other Community-acquired Pneumonia trials with a reported enrollment target (98% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Community-acquired Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Immediate Antibiotic Prescribing Group Instructions is the first listed.

NCT06986148 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06986148 about?

NCT06986148 is a clinical study titled "Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)". The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main ai...

What is the current status of trial NCT06986148?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-09-09. Estimated completion is 2029-07-16.

What conditions does trial NCT06986148 study?

This clinical trial studies the following conditions: Community-acquired Pneumonia, Community Acquired Pneumonia (CAP).

What interventions are being tested in trial NCT06986148?

The interventions under investigation include: Immediate Antibiotic Prescribing Group Instructions (OTHER), Safety Net Antibiotic Prescribing (SNAP) Group Instructions (OTHER).

Who is sponsoring clinical trial NCT06986148?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986148 being conducted?

This trial has 4 study locations across Georgia, Illinois, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Community-acquired Pneumonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.